Argos Therapeutics Inc fka ARGSQ

[maverick_1]

WOW 2 weeks later and ARGS falling ~$2 and still NO resolution of:
1) Underwriters taking the HIT for 9 mln shs offering@ $5.50/shr until distributed: low demand!
2) LARGE Overhang of registration of Original Shareholders will continue to plague upside
for ARGS should even # 1) be resolved.

Simply contrast ALL of the above with AMRN's 21 mln shs @$2.85 at a very large discount BUT:
AMRN shs closed@ $3.07 on 11 mln shs and NEVER selling below the offering which is scheduled to close August 16th. BTW the low was way above $2.85 AND closed near the highs of the day.

SO HOW DOES an ARGS shrhlder explain the ACTUAL REAL LIVE MARKET ACTION DIFFERENCE between AMRN AND ARGS???

Preconceived notions or past historical examples are NOT relevant: not a science but all relevant to circumstances unique to companies cited.

IF one does not know the answer one should question one's understanding of the investing process... forget about speculation.

Class dismissed.